New York, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Market Overview: The INR (International Normalized Ratio) Test Meter Market has witnessed substantial growth in recent years, driven by the increasing ...
The INR test meter market is poised for significant growth in the coming decade, propelled by rising incidences of cardiovascular diseases and blood disorders worldwide. According to recent market ...
Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...
A new recall has been issued CoaguChek XS PT test strips, used to monitor international normalized ratio (INR) in patients taking warfarin, due to inaccurately high readings. Roche Diagnostics ...
Please provide your email address to receive an email when new articles are posted on . At-home patient self-monitoring of warfarin therapy yielded similar results to monitoring performed in a clinic ...
Concerned over nine serious adverse events, three of which described bleeding associated with patient deaths, Alere Inc. of Waltham, MA issued a voluntary urgent recall of its PN 99008G2 INRatio2 ...
Individuals taking warfarin who engaged in weekly patient self-testing (PST) had significant improvement in control of warfarin compared to patients who had variable (1–4 tests per month) self-testing ...
The INR test meter market is set for significant growth, with an estimated market size of USD 1,336.1 million in 2023. According to Future Market Insights, the market is projected to expand at a ...
(HealthDay)—For stable warfarin-treated patients, extended international normalized ratio (INR) testing can be successfully and safely implemented, according to a study published online May 15 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results